The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR(PDF, 524KB) and Technical Notes(PDF, 752KB) pages.


Download and Print: Download Printer-friendly PDF Download data

Table 18.21

Myeloma (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2014
By Race/Ethnicity, Sex and Years Since Diagnosis

WARNING: The Prevalence Estimates presented on this page utilize a different tumor selection criteria from previous CSR releases and are NOT directly comparable to estimates from previous CSR releases.
Please see the Prevalence Comparison Chapter of this CSR for more information.

Race/Ethnicity Sex Years Since Diagnosis Completeh
0 to <5 5 to <10 10 to <15 15 to <20 20 to <25 25 to <30 0 to <22e 0 to <39e >=39g
All Races b Both Sexes 75,648 26,835 9,541 3,669 1,720 599 117,239 118,272 267 118,539
Males 42,231 14,340 5,108 2,061 995 332 64,628 65,186 97 65,283
Females 33,417 12,495 4,433 1,608 725 267 52,611 53,086 170 53,256
White b Both Sexes 56,591 20,554 7,528 2,907 1,340 452 88,814 89,550 0 89,550
Males 32,622 11,414 4,199 1,660 768 266 50,593 51,023 0i 51,023
Females 23,969 9,140 3,329 1,247 572 186 38,221 38,527 0i 38,527
Black b Both Sexes 15,605 5,196 1,693 592 286 111 23,324 23,560 + +
Males 7,769 2,414 747 299 191 61 11,383 11,505 + +
Females 7,836 2,782 946 293 95 50 11,941 12,055 + +
Asian/
Pacific
Islander c		 Both Sexes 1,934 650 214 91 + + 2,927 + + +
Males 1,040 307 104 45 + + 1,509 + + +
Females 894 343 110 46 + + 1,418 + + +
Hispanic d Both Sexes 5,519 1,700 842 270 + + 8,382 + + +
Males 3,117 954 449 177 + + 4,728 + + +
Females 2,402 746 393 93 + + 3,654 + + +

Estimated prevalence percent a on January 1, 2014, of the SEERc population diagnosed in the previous 22 years
By Age at Prevalence, Race/Ethnicity and Sex

WARNING: The Prevalence Estimates presented on this page utilize a different tumor selection criteria from previous CSR releases and are NOT directly comparable to estimates from previous CSR releases.
Please see the Prevalence Comparison Chapter of this CSR for more information.

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedf
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races c Both Sexes 0.0323% - - 0.0003% 0.0025% 0.0131% 0.0403% 0.1000% 0.1719% 0.1637% 0.0300%
Males 0.0362% - - 0.0004% 0.0029% 0.0158% 0.0459% 0.1161% 0.2179% 0.2226% 0.0370%
Females 0.0284% - - 0.0003% 0.0020% 0.0104% 0.0350% 0.0854% 0.1343% 0.1282% 0.0243%
White c Both Sexes 0.0320% - - 0.0004% 0.0023% 0.0117% 0.0369% 0.0931% 0.1649% 0.1597% 0.0283%
Males 0.0369% - - 0.0005% 0.0029% 0.0142% 0.0435% 0.1114% 0.2102% 0.2251% 0.0357%
Females 0.0271% - - 0.0003% 0.0017% 0.0091% 0.0304% 0.0759% 0.1268% 0.1197% 0.0222%
Black c Both Sexes 0.0511% - - - 0.0046% 0.0301% 0.0825% 0.2100% 0.3318% 0.3060% 0.0600%
Males 0.0530% - - - 0.0046% 0.0351% 0.0838% 0.2297% 0.4388% 0.4058% 0.0719%
Females 0.0494% - - - 0.0046% 0.0258% 0.0814% 0.1946% 0.2573% 0.2566% 0.0522%
Asian/
Pacific
Islander c		 Both Sexes 0.0178% - - - 0.0014% 0.0066% 0.0227% 0.0561% 0.0993% 0.1015% 0.0172%
Males 0.0189% - - - 0.0015% 0.0095% 0.0263% 0.0615% 0.1190% 0.1133% 0.0201%
Females 0.0168% - - - 0.0012% 0.0040% 0.0197% 0.0516% 0.0840% 0.0942% 0.0148%
Hispanic d Both Sexes 0.0158% - - 0.0004% 0.0028% 0.0113% 0.0356% 0.0804% 0.1498% 0.1259% 0.0253%
Males 0.0176% - - - 0.0036% 0.0141% 0.0426% 0.0965% 0.1762% 0.1847% 0.0315%
Females 0.0140% - - - 0.0020% 0.0083% 0.0288% 0.0664% 0.1301% 0.0904% 0.0206%

Footnotes:

a US 2014 cancer prevalence counts are based on 2014 cancer prevalence proportions from the SEER registries and 1/1/2014 US population estimates based on the average of 2013 and 2014 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 39/22 years.

b Statistics based on SEER 9 Areas.

c Statistics based on SEER 13 Areas excluding the Alaska Native Registry

d Statistics based on NHIA for Hispanic for SEER 13 Areas excluding the Alaska Native Registry.

e Maximum limited-duration prevalence: 39 years for 1975-2014 SEER 9 data; 22 years for 1992-2014 SEER 13 data (excluding the Alaska Navtive Registry) used to calculate prevalence for Hispanics and Asian Pacific Islanders.

f Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

g Cases diagnosed more than 39 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

h Complete prevalence is obtained by summing 0 to <39 and >=39.

i Age-specific completeness index was approximated using empirical data from historical Connecticut tumor registry.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.